By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
The Nile Wires
Ad imageAd image
  • News
    • Regional
    • International
    • National
  • Politics
  • Business
  • Opinion
  • Defence & Security
  • Tourism
  • Technology
  • Sports
  • +MORE
    • Education
    • Lifestyle
    • Health
    • Crime
Reading: Multi-Drug-Resistant TB Drug Irks Adjumani Locals
Search
The Nile WiresThe Nile Wires
Font ResizerAa
Search
  • News
    • Regional
    • International
    • National
  • Politics
  • Business
  • Opinion
  • Defence & Security
  • Tourism
  • Technology
  • Sports
  • +MORE
    • Education
    • Lifestyle
    • Health
    • Crime
Have an existing account? Sign In
Follow US
© The Nile Wires. All Rights Reserved.
The Nile Wires > Featured > Multi-Drug-Resistant TB Drug Irks Adjumani Locals
FeaturedHealth

Multi-Drug-Resistant TB Drug Irks Adjumani Locals

Alen Nafuna
Last updated: April 12, 2024 6:28 am
By
Alen Nafuna
2 Min Read
Share
SHARE

Officials from the Ministry of Health in Adjumani district have reported a surge in tuberculosis (TB) cases among both refugee communities and nationals.

According to reports, there have been 77 cases of multi-drug-resistant TB (MDR TB), which occurs when TB bacteria develop resistance to at least isoniazid and rifampin, the two most effective TB drugs.

Dr. Dominic Drametu, the District Health Officer of Adjumani, noted that some of these cases resulted from low-level detection. Out of the 77 cases, 76 were identified through point-of-care tests (POCTs), which enable early detection, immediate treatment, and reduced transmission of TB disease. Currently, 16 patients are undergoing active treatment with a combination of antibacterial medications for a duration of six to 12 months.

Dr. Drametu made these remarks on April 11, 2024, at the Adjumani District Health Offices while addressing district health workers.

He highlighted the low levels of early disease detection, attributing it to excessive reliance on TB Gene Xpert machines, rapid tests capable of simultaneously identifying Mycobacterium tuberculosis and rifampin resistance from sputum.

Emmanuel Ainebyoona, the spokesperson for the Ministry of Health, acknowledged TB’s prevalence nationwide, emphasizing the importance of prevention measures and treatment adherence for those diagnosed.

“A substantial increase in testing is imperative. Individuals should allocate two weeks for TB testing. Early detection is paramount, as is prevention, including avoiding living in congested settlements,” Ainebyoona remarked.

He further urged settlement authorities to implement measures to prevent further spread by de-congesting areas. Given TB’s omnipresence, he stressed the necessity of comprehensive preventative measures and their strict adherence.

The World Health Organization (WHO) conducted a mid-term review of Uganda’s tuberculosis response, highlighting its status as one of the world’s deadliest infectious diseases and a growing challenge in Uganda. Annually, close to 240 individuals fall ill with TB, resulting in approximately 30 fatalities, with over half of TB-related deaths occurring among people living with HIV.

Share This Article
Facebook Whatsapp Whatsapp

You Might Also Like

Defence & SecurityFeaturedNational

President Museveni Applauds Parliament on Passing UPDF Amendment Bill, 2025,

By
Phillipa Among
5 Min Read
FeaturedNews

Mufti Mubaje Warns Against Using Mosques for Political Campaigns

By
Phillipa Among
4 Min Read
FeaturedPolitics

People’s Front for Freedom Party Receives Registration Certificate from Electoral Commission

By
Phillipa Among
2 Min Read
The Nile Wires
Our dedicated team of journalists brings you accurate and reliable news coverage, keeping you updated on the stories that matter.

Categories

  • News
    • Regional
    • International
    • National
  • Politics
  • Business
  • Opinion
  • Defence & Security
  • Tourism
  • Technology
  • Sports
  • +MORE
    • Education
    • Lifestyle
    • Health
    • Crime

Quick Links

  • Advertise with us
  • Newsletters
  • Complaint
  • Deal

Copyright 2025. Nile Wires. All Rights Reserved.

Copyright 2025. Nile Wires. All Rights Reserved
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?